Health Catalyst, Inc.
HCAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $307 | $296 | $276 | $242 |
| % Growth | 3.6% | 7.1% | 14.2% | – |
| Cost of Goods Sold | $166 | $164 | $143 | $124 |
| Gross Profit | $141 | $132 | $133 | $118 |
| % Margin | 45.9% | 44.5% | 48.2% | 48.6% |
| R&D Expenses | $58 | $73 | $76 | $63 |
| G&A Expenses | $57 | $77 | $62 | $86 |
| SG&A Expenses | $111 | $144 | $149 | $161 |
| Sales & Mktg Exp. | $54 | $67 | $88 | $75 |
| Other Operating Expenses | $41 | $42 | $48 | $38 |
| Operating Expenses | $211 | $259 | $273 | $261 |
| Operating Income | -$70 | -$127 | -$140 | -$144 |
| % Margin | -22.8% | -42.9% | -50.7% | -59.4% |
| Other Income/Exp. Net | $1 | $9 | -$2 | -$16 |
| Pre-Tax Income | -$69 | -$118 | -$142 | -$160 |
| Tax Expense | $0 | $0 | -$4 | -$7 |
| Net Income | -$70 | -$118 | -$137 | -$153 |
| % Margin | -22.7% | -39.9% | -49.7% | -63.3% |
| EPS | -1.15 | -2.09 | -2.56 | -3.23 |
| % Growth | 45% | 18.4% | 20.7% | – |
| EPS Diluted | -1.15 | -2.09 | -2.54 | -3.23 |
| Weighted Avg Shares Out | 60 | 56 | 54 | 47 |
| Weighted Avg Shares Out Dil | 60 | 56 | 54 | 47 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18 | $16 | $6 | $1 |
| Interest Expense | $17 | $7 | $7 | $17 |
| Depreciation & Amortization | $41 | $42 | $52 | $41 |
| EBITDA | -$11 | -$68 | -$83 | -$102 |
| % Margin | -3.5% | -23.1% | -30% | -42% |